Status:
UNKNOWN
Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
Lead Sponsor:
Cairo University
Conditions:
Premature Ejaculation
Eligibility:
MALE
20-59 years
Phase:
EARLY_PHASE1
Brief Summary
Escitalopram has been claimed to have the highest selectivity for the human serotonin transporter relative to the noradrenaline or dopamine transporters. This might be associated with greater clinical...
Detailed Description
Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized controlled Study Introduction From an epidemiological perspec...
Eligibility Criteria
Inclusion
- One hundred married patients seek medical help for what they consider premature ejaculation with possible sexual intercourse equal or greater than 1 per week.
Exclusion
- Erectile dysfunction accounting to Arabic version of IIEF(International Index of Erectile Dysfunction)
- Chronic psychiatric or physical illness.
- Alcohol or substance abuse.
- Use of psychotropic and antidepressant medication.
- Patient with prostatitis
- Organic illness causing limitation of SSRI use.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00656552
Start Date
May 1 2008
Last Update
April 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr el ainy school of medicine , Cairo university
Cairo, Egypt